Hercules Achieves Nearly $900MM in Origination Commitments
Hercules Technology Growth Capital announced its Q4/14 portfolio update with nearly $900 million in origination commitments.
Hercules Technology Growth Capital announced its Q4/14 portfolio update with nearly $900 million in origination commitments.
ADMA Biologics, a late stage biopharmaceutical company, received a $5 million tranche from Hercules Technology Growth Capital.
Genocea Biosciences entered into a loan and security agreement with Hercules Technology Growth Capital for a term loan of up to $27 million.
Baxano Surgical filed for Chapter 11 to facilitate a going concern sale of its minimally invasive products under §363. Pre-petition lender Hercules Technology Growth Capital will provide the DIP financing.
Ultura reportedly filed a Chapter 11 petition in Delaware to sell its membrane business to pre-bankruptcy lender UAC Finance in exchange for about $25 million of debt, absent a better bid at auction.
Hercules Technology Growth Capital announced strong Q3/14 portfolio activity.
Hercules Technology Growth Capital said it amended its credit facility with MUFG Union Bank increasing its size to $75 million from $30 million. An accordion feature could increase the size to $95 million.
Celladon announced it entered into a credit facility with Hercules Technology Growth Capital and its affiliate lenders. The facility provides for up to $25 million of loans.
Amedica Corporation announced it has secured up to $26 million in additional funding, including a $20 million debt financing with Hercules Technology Growth Capital.
Alimera Sciences announced that its UK subsidiary entered into a four-year, $35 million term loan with Hercules Technology Growth Capital. The initial $10 million funding will be used to pay off existing debt.